Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

C-Reactive protein-to-albumin ratio

  • Open Access
    Factors for Discontinuation of Naldemedine Therapy in a Palliative Ward
    TAKAKI KANIE, TOMOHIRO MIZUNO, TAKENAO KOSEKI, AYA HANAMOTO, HIROKO SAWANO, MASAKO TOMIDA, YUKIKO KAKUMAE, TAKAHIRO HAYASHI, HIROSHI MATSUOKA, MASANOBU USUI and SHIGEKI YAMADA
    In Vivo May 2025, 39 (3) 1647-1653; DOI: https://doi.org/10.21873/invivo.13965
  • Open Access
    C-reactive Protein-to-Albumin Ratio Predicts Conversion from Laparoscopic to Open Cholecystectomy in Acute Cholecystitis
    MASASHI UTSUMI, MASARU INAGAKI, KOJI KITADA, NAOYUKI TOKUNAGA, KOSUKE YUNOKI, YUYA SAKURAI, RYOSUKE HAMANO, YOUSUKE TSUNEMITSU, HIDEAKI MIYASOU and SHINYA OTSUKA
    In Vivo March 2023, 37 (2) 887-893; DOI: https://doi.org/10.21873/invivo.13157
  • You have access
    Prognostic Impact of Inflammation-related Biomarkers on Overall Survival of Patients with Inoperable Malignant Pleural Mesothelioma
    TAKEHIRO OTOSHI, YUKI KATAOKA, SAWAKO KAKU, REIKA IKI and MASATAKA HIRABAYASHI
    In Vivo March 2018, 32 (2) 445-450;
In Vivo

© 2026 In Vivo

Powered by HighWire